ScoreWhy is Hubei Hongyuan Pharmaceutical Technology Co., Ltd. ?
1
With a growth in Net Profit of 1524.43%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- ROCE(HY) Highest at 5.68%
- RAW MATERIAL COST(Y) Fallen by -197.79% (YoY)
- NET SALES(Q) Highest at CNY 703.53 MM
2
With ROE of 5.51%, it has a very attractive valuation with a 0.99 Price to Book Value
- Over the past year, while the stock has generated a return of 87.12%, its profits have risen by 875% ; the PEG ratio of the company is 0
3
Market Beating Performance
- The stock has generated a return of 87.12% in the last 1 year, much higher than market (China Shanghai Composite) returns of 19.22%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Hubei Hongyuan Pharmaceutical Technology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hubei Hongyuan Pharmaceutical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
73.51%
1.65
59.89%
China Shanghai Composite
19.22%
1.40
13.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.91%
EBIT Growth (5y)
-16.28%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.36
Tax Ratio
12.27%
Dividend Payout Ratio
16.67%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.26%
ROE (avg)
10.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
0.99
EV to EBIT
15.18
EV to EBITDA
9.54
EV to Capital Employed
0.99
EV to Sales
1.80
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
6.52%
ROE (Latest)
5.51%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend34What is working for the Company
ROCE(HY)
Highest at 5.68%
RAW MATERIAL COST(Y)
Fallen by -197.79% (YoY
NET SALES(Q)
Highest at CNY 703.53 MM
PRE-TAX PROFIT(Q)
Highest at CNY 143.99 MM
NET PROFIT(Q)
Highest at CNY 143.09 MM
EPS(Q)
Highest at CNY 0.36
-5What is not working for the Company
INTEREST(HY)
At CNY 9.49 MM has Grown at 54.26%
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.95 times
Here's what is working for Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Pre-Tax Profit
At CNY 143.99 MM has Grown at 1,072.22%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 143.09 MM has Grown at 2,357.9%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 703.53 MM has Grown at 62.31%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Net Sales
Highest at CNY 703.53 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 143.99 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 143.09 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.36
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -197.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Interest
At CNY 9.49 MM has Grown at 54.26%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 4.95 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
